当前位置:
X-MOL 学术
›
Drug Alcohol Rev.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
COVID-19 vaccination coverage and vaccine hesitancy among people with opioid use disorder in Barcelona, Spain
Drug and Alcohol Review ( IF 4.042 ) Pub Date : 2022-06-06 , DOI: 10.1111/dar.13502 Gabriel Vallecillo 1, 2 , Xavier Durán 3 , Irene Canosa 1 , Albert Roquer 1 , Maria C Martinez 1 , Rafael Perelló 4
Drug and Alcohol Review ( IF 4.042 ) Pub Date : 2022-06-06 , DOI: 10.1111/dar.13502 Gabriel Vallecillo 1, 2 , Xavier Durán 3 , Irene Canosa 1 , Albert Roquer 1 , Maria C Martinez 1 , Rafael Perelló 4
Affiliation
People with substance use disorders are considered a priority group for SARS-CoV-2 vaccination as they are at elevated risk of COVID-19 and its severe complications. However, data are scarce about vaccination coverage in a real-world setting.
中文翻译:
西班牙巴塞罗那阿片类药物使用障碍患者的 COVID-19 疫苗接种覆盖率和疫苗犹豫情况
患有物质使用障碍的人被认为是 SARS-CoV-2 疫苗接种的优先群体,因为他们感染 COVID-19 及其严重并发症的风险较高。然而,关于现实世界中疫苗接种覆盖率的数据很少。
更新日期:2022-06-06
中文翻译:
西班牙巴塞罗那阿片类药物使用障碍患者的 COVID-19 疫苗接种覆盖率和疫苗犹豫情况
患有物质使用障碍的人被认为是 SARS-CoV-2 疫苗接种的优先群体,因为他们感染 COVID-19 及其严重并发症的风险较高。然而,关于现实世界中疫苗接种覆盖率的数据很少。